Molecular actions of prolactin in the immune system

Proceedings of the Society for Experimental Biology and Medicine

Volumn 215, Issue 1, 1997, Pages 35-52

  Yu Lee, Li Yuan ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR;

HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PROTEIN FAMILY; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0030903318     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-215-44111     Document Type: Short Survey

References (298)

1. Southard JN, Talamantes F. Placental prolactin-like proteins in rodents: Variations on a structural theme. Mol Cell Endocrinol 79:133-140, 1991.
2. Soares MJ, Faria TN, Roby KF, Deb S. Pregnancy and the prolactin family of hormones: Coordination of anterior pituitary, uterine, and placental expression. Endocr Rev 12:402-423, 1991.
3. Hobbs AA, Richards DA, Kessler DJ, Rosen JM. Complex hormonal regulation of rat casein gene expression. J Biol Chem 257:3598-3605, 1982.
4. Krasnow JS, Hickey GJ, Richards JS. Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol Endocrinol 4:13-21, 1990.
5. Nevalainen MT, Valve EM, Makela SI, Blauer M, Tuohimaa PJ, Harkonen PL. Estrogen and prolactin regulation of rat dorsal and lateral prostate in organ culture. Endocrinology 129:612-622, 1991.
6. Montgomery DW, Shen GK, Ulrich ED, Steiner LL, Parrish PR, Zukoski CF. Human thymocytes express a prolactin-like mRNA and synthesize bioactive prolactin-like proteins. Endocrinology 131:3019-3026, 1992.
7. O'Neal KD, Montgomery DW, Truong TM, Yu-Lee L-Y. Prolactin gene expression in human thymocytes. Mol Cell Endocrinol 87:R19-R23, 1992.
8. Pellegrini I, Lebrun J-J, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 6:1023-1031, 1992.
9. Jurcovicova J, Day RN, MacLeod RM. Expression of prolactin in rat lymphocytes. Prog Neuro Endocrin Immunol 5:256-263, 1992.
10. Hartmann DP, Holaday JW, Bernton EW. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 3:2194-2202, 1989.
11. Sabharwal P, Glaser R, LaFuse W, Varma S, Liu Q, Arkins S, Kooijman R, Kutz L, Kelley KW, Malarkey WB. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci 89:7713-7716, 1992.
12. Bazan JF. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun 164:788-795, 1989.
13. Cosman D. The hematopoietin receptor superfamily. Cytokine 5:95-106, 1993.
14. Bernton EW, Bryant HU, Holaday JW. Prolactin and Immune Function. Psychoneuroimmunology. New York: Academic Press, pp 403-428, 1991.
15. Hooghe R, Delhase M, Vergani P, Malur A, Hooghe-Peters EL. Growth hormone and prolactin are paracine growth and differentiation factors in the haemopoietic system. Immunol Today 14:212-214, 1993.
16. Horseman ND, Yu-Lee L-Y. Transcriptional regulation by the helix bundle peptide hormones: Growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev 15:627-649, 1994.
17. Murphy WJ, Rui H, Longo DL. Effects of growth hormone and prolactin in immune development and function. Life Sci 57:1-14, 1995.
18. Gala RR. Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med 198:513-527, 1991.
19. Savino W, Dardenne M. Immune-neuroendocrine interactions. Immunol Today 16:318-322, 1995.
20. Weigent DA. Immunoregulatory properties of growth hormone and prolactin. Pharmacol Ther 69:237-257, 1996.
21. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 59:599-614, 1996.
22. Doppler W. Regulation of gene expression by prolactin. Rev Physiol Biochem Pharmacol 124:93-130, 1994.
23. Groner B, Gouillex F. Prolactin-mediated gene activation in mammary epithelial cells. Curr Opin Genet Dev 5:587-594, 1995.
24. Rosen JM, Zahnow C, Kazansky AV, Raught B. Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. In: Biochemical Society Annual Symposium. Rudland PS, Fernig D, Leinster S, Eds. London: Portland Press (in press), 1997.
25. Lahita RG. The importance of estrogens in systemic lupus erythematosus. Clin Immunol Immunopathol 63:17-18, 1992.
26. Lieberman ME, Maurer RA, Gorski J. Estrogen control of prolactin synthesis in vitro. Proc Natl Acad Sci 75:5946-5949, 1978.
27. Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, Gonzalez-Barcena D, Fraga A. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheum 14:268-272, 1987.
28. Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 303:222-226, 1992.
29. Kira JI, Harada M, Yamaguchi Y, Shida N, Goto I. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 102:61-66, 1991.
30. Chikanza IC, Petrou P, Chrousos G, Kingsley G, Panayi GS. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: Immunopathogenetic and therapeutic implications. Br J Rheumatol 32:445-448, 1993.
31. McMurray RW, Allen SH, Pepmueller PH, Keisler D, Cassidy JT. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity. J Rheum 22:1577-1580, 1995.
32. Buskila D, Sukenik S, Holcberg G, Horowitz J. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia. J Rheum 18:611-612, 1991.
33. Graef AS, Gonzalez SS, Baca VR, Ramirez ML, Daza LB, Blanco FF, Ortiz OA, Lavalle CM. High serum prolactin levels in asymptomatic HIV-infected patients and in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 72:390-393, 1994.
34. Carrier M, Emery RW, Wild-Mobley J, Perrotta NJ, Russell DH, Copeland JG. Prolactin as a marker of rejection in human heart transplantation. Transplant Proc 19:3442-3443, 1987.
35. Berczi I, Cosby H, Hunter T, Baragar F, McNeilly AS, Friesen HG. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Br J Rheumatol 26:433-436, 1987.
36. Palestine AG, Nussenblatt RB. The effect of bromocriptine on anterior uveitis. Am J Ophthalmol 106:488-489, 1988.
37. Geffner ME, Lippe BM. The role of immunotherapy in Type I diabetes mellitus. West J Med 146:337-343, 1987.
38. Vidaller A, Guadarrama F, Llorente L, Mendez JP, Larrea F, Villa AR, Alarcon-Segovia D. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient. J Clin Immunol 12:210-215, 1992.
39. Leite-de-Moraes MC, Touraine, P, Kelly PA, Kuttenn F, Dardenne M. Prolactin receptor expression in lymphocytes from patients with hyperprolactinemia or acromegaly. J Endocrinol 147:353-359, 1995.
40. Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol 102:351-357, 1983.
41. Nagy E, Berczi I. Pituitary dependence of bone marrow function. Br J Haematol 71:457-462, 1989.
42. 3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci 83:5663-5667, 1986.
43. - lymphocytes in thymus glands of aged rats. Endocrinology 130:2703-2709, 1992.
44. Neidhart M, Fluckiger EW. Hyperprolactinaemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 77:449-455, 1992.
45. Riskind PN, Massacesi L, Doolittle TH, Hauser SL. The role of prolactin in autoimmune demyelination: Suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 29:542-547, 1991.
46. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 147:3780-3787, 1991.
47. Walker SE, Allen SH, McMurray RW. Prolactin and autoimmune disease. Trends Endocrinol Metab 4:147-151, 1993.
48. Murphy WJ, Durum SK, Longo DL. Differential effects of growth hormone and prolactin on murine T cell development and function. J Exp Med 178:231-236, 1993.
49. Gala RR, Shevach EM. Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proc Soc Exp Biol Med 204:224-230, 1993.
50. Gaufo GO, Diamond MC. Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc Natl Acad Sci 93:4165-4169, 1996.
51. Matera L, Bellone G, Cesano A. Prolactin and the neuroimmune network. Adv Neuroimmunol 1:158-172, 1991.
52. Clodi M, Svoboda T, Kotzmann H, Deyssig R, Woloszczuk W, Zielinski CC, Luger A. Effect of elevated serum prolactin concentrations on cytokine production and natural killer cell activity. Neuroendocrinol 56:775-779, 1992.
53. Bellone G, Geuna M, Carbone A, Silvestri S, Foa R, Emanuelli G, Matera L. Regulatory action of prolactin on the in vitro Growth of CD34+ve human hemopoietic progenitor cells. J Cell Physiol 163:221-231, 1995.
54. Cincotta AH, Knisely TL, Landry RJ, Miers WR, Gutierrez PJA, Esperanza P, Meier AH. The immunoregulatory effects of prolactin in mice are time of day dependent. Endocrinology 136:2163-2171, 1995.
55. Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239:401-404, 1989.
56. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action of cyclosporine. Proc Natl Acad Sci 83:2599-2603, 1986.
57. Morikawa K, Oseko F, Morikawa S. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin Exp Immunol 95:514-518, 1994.
58. Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, Goldberg I, Shoenfeld Y. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol 162:114-122, 1995.
59. Montgomery DW, Zukoski, CF, Shah GN, Buckley AR, Pacholczyk T, Russell DH. Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun 145:692-698, 1987.
60. Skwarlo-Sonta K. Mitogenic effect of prolactin on chicken lymphocytes in vitro. Immunol Lett 24:171-178, 1990.
61. Viselli SM, Stanek, EM, Mukherjee P, Hymer WC, Mastro AM. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 129:983-989, 1991.
62. Clevenger CV, Sillman AL, Prystowsky MB. Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes. Endocrinology 127:3151-3159, 1990.
63. Yu-Lee L-Y. Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol 68:21-28, 1990.
64. Gout PW, Beer CT, Noble RL. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 40:2433-2436, 1980.
65. Yu-Lee L-Y, Hrachovy JA, Stevens AM, Schwarz LA. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol 10:3087-3094, 1990.
66. Mukherjee P, Mastro AM, Hymer WC. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 126:88-94, 1990.
67. Gala RR, Shevach EM. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 133:1617-1623, 1993.
68. Gagnerault M-C, Touraine P, Savino W, Kelly PA, Dardenne M. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 150:5673-5681, 1993.
69. O'Neal KD, Schwarz LA, Yu-Lee L-Y. Prolactin receptor gene expression in lymphoid cells. Mol Cell Endocrinol 82:127-135, 1991.
70. Dardenne M, Leite de Moraes M, Kelly PA, Gagnerault M-C. Prolactin receptor expression in human hematopoietic tissues analysed by flow cytoflourometry. Endocrinology 134:2108-2114, 1994.
71. Fletcher-Chiappini SE, Comptom MM, La Voie HA, Day EB, Witorsch RJ. Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticytolytic effects. Proc Soc Exp Biol Med 202:345-352, 1993.
72. LaVoie HA, Witorsch RJ. Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells. Proc Soc Exp Biol Med 209:257-269, 1995.
73. Lahat N, Miller A, Shtiller R, Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 47:35-40, 1993.
74. Kenner JR, Holaday JW, Bernton WEW. Prolactin-like protein in murine splenocytes: Morphological and biochemical evidence. Prog NeuroEndocrinImmunol 3:188-195, 1990.
75. Wu H, Devi R, Malarkey WB. Expression and localization of prolactin messenger ribonucleic acid in the human immune system. Endocrinology 137:349-353, 1996.
76. Ben-Jonathan N, Mershon J, Allen D, Steinmetz R. Extrapituitary prolactin: Distribution, regulation, functions and clinical aspects. Endocr Rev 19:639-669, 1996.
77. Rao Y-P, Buckley DJ, Olson MD, Buckley AR. Nuclear translocation of prolactin: Collaboration of tyrosine kinase and protein kinase C activation in rat Nb2 node lymphoma cells. J Cell Physiol 163:266-267, 1995.
78. Gala RR, Rillema JA. Evaluation of prolactin-like activity produced by concanavalin-A stimulated mouse splenocytes. Life Sci 57:1683-1700, 1995.
79. DiMattia GE, Gellersen B, Duckworth ML, Friesen HG. Human prolactin gene expression: The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem 265:16412-16421, 1990.
80. Gellersen B, Kempf R, Telgmann R, DiMattia GE. Nonpituitary human prolactin gene transcriptin is independent of pit-1 and differentially controlled in lymphocytes and endometrial stroma. Mol Endocrinol 8:356-373, 1994.
81. Gellersen B, Kempf R, Telgmann R, DiMattia GE. Pituitary-type transcription of the human prolactin gene in the absence of pit-1. Mol Endocrinol 9:887-901, 1995.
82. Ali S, Edery M, Pellegrini I, Lesueur L, Paly J, Djiane J, Kelly PA. The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter. Mol Endocrinol 6:1242-1248, 1992.
83. Touraine P, Carmo Leite de Moraes M, Dardenne M, Kelly PA. Expression of short and long forms of prolactin receptor in murine lymphoid tissues. Mol Cell Endocrinol 104:183-190, 1994.
84. Gunes H, Mastro AM. Prolactin receptor gene expression in rat splenocytes and thymocytes from birth to adulthood. Mol Cell Endocrinol 117:41-52, 1996.
85. Viselli SM, Mastro AM. Prolactin receptors are found on heterogeneous subpopulations of rat splenocytes. Endocrinology 132:571-576, 1993.
86. Okamura H, Zachwieja J, Raguet S, Kelly PA. Characterization and applications of monoclonal antibodies to the prolactin receptor. Endocrinology 124:2499-2508, 1989.
87. Kincade PW, Lee G, Pietrangeli CE, Hayashi S-I, Gimble JM. Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu Rev Immunol 7:111-143, 1989.
88. McAveney KM, Gimble JM, Yu-Lee L-Y. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. Endocrinol 137:5723-5726, 1996.
89. Clevenger CV, Russell DH, Appasamy PM, Prystowsky MB. Regulation of IL2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci 87: 6460-6464, 1990.
90. O'Neal KD, Yu-Lee L-Y. The proline-rich motif (PRM): A novel feature of the cytokine/hematopoietin receptor superfamily. Lymph Cyt Res 12:309-312, 1993.
91. Bazan JF. Shared architecture of hormone binding domains in type I and II interferon receptors. Cell 61:753-754, 1990.
92. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci 88: 11349-11353, 1991.
93. Kelly PA, Djiane J, Postel-Vinay M-C, Edery M. The prolactin/ growth hormone receptor family. Endocr Rev 12:235-251, 1991.
94. Davis JA, Linzer DIH. Expression of multiple forms of the prolactin receptor in mouse liver. Mol Endocrinol 3:674-680, 1989.
95. O'Neal KD, Yu-Lee L-Y. Differential signal transduction of the short, Nb2, and long PRL receptor: Activation of IRF-1 and cell proliferation. J Biol Chem 269:26076-26082, 1994.
96. Boutin J-M, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, Banville D, Dusanter-Fourt I, Djiane J, Kelly PA. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53:69-77, 1988.
97. Ali S, Pellegrini I, Kelly PA. A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J Biol Chem 266:20110-20117, 1991.
98. Clevenger CV, Chang WP, Ngo W, Pasha TLM, Montone KT, Tomaszweski JE. Expression of prolactin and prolactin receptor in human breast carcinoma. Am J Pathol 146:695-705, 1995.
99. Nagano M, Kelly PA. Tissue distribution and regulation of rat prolactin receptor gene expression. J Biol Chem 269:13337-13345, 1994.
100. DaSilva L, Howard OMZ, Rui H, Kirken RA, Farrar WL. Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. J Biol Chem 269:18267-18270, 1994.
101. Chang W-P, Clevenger CV. Modulation of growth factor receptor function by isoform heterodimerization. Proc Natl Acad Sci 93:5947-5952, 1996.
102. Velazquez L, Fellous M, Stark GR, Pellegrini S. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70:313-322, 1992.
103. Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zurcher G, Ziemiecki A. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 11:2057-2065, 1991.
104. Ziemiecki A, Harpur AG, Wilks AF. JAK protein tyrosine kinases: Their role in cytokine signalling. Trends Cell Biol 4:207-212, 1994.
105. Takahashi T, Shirasawa T. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases. FEBS lett 342:124-128, 1994.
106. Kirken RA, Rui H, Malabarba MG, Farrar WL. Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. J Biol Chem 269:19136-19141, 1994.
107. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236, 1993.
108. Igarashi K, Garotta G, Ozmen L, Ziemiecki A, Wilks AF, Harpus AG, Larner AC, Finbloom DS. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J Biol Chem 269:14333-14336, 1994.
109. Rui H, Kirken RA, Farrar WL. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 269:5364-5368, 1994.
110. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, Ihle JN, Yancopoulos GD. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95, 1994.
111. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244, 1993.
112. Darnell JE Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421, 1994.
113. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: The Jak-STAT pathway. Annu Rev Biochem 64:621-651, 1995.
114. 2 rat lymphoma cells. J Biol Chem 265:14770-14776, 1990.
115. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci 91:5232-5236, 1994.
116. Lebrun J, Ali S, Sofer L, Ullrich A, Kelly PA. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem 269:14021-14026, 1994.
117. Lebrun J, Ali S, Ullrich A, Kelly PA. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem 270:10664-10670, 1995.
118. Lebrun J, Suhad A, Goffin V, Ullrich A, Kelly PA. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc Natl Acad Sci 92:4031-4035, 1995.
119. O'Neal KD, Yu-Lee L-Y, Shearer WT. The proline-rich motif is necessary but not sufficient for prolactin receptor signal transduction. Ann NY Acad Sci 766:282-284, 1995.
120. Fukunaga R, Ishizaka-Ikeda E, Pan C-X, Seto Y, Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 10:2855-2865, 1991.
121. Takaki S, Kanazawa H, Shiiba M, Takatsu K. A critical cytoplasmic domain of the interluekin-5 (IL-5) receptor α chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol 14:7404-7413, 1994.
122. Goujon L, Allevato G, Simmon G, Paquereau L, Le Cam A, Clark J, Nilesen JH, Djiane J, Postel-Vinay M-C, Edery M, Kelly PA. Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction. Proc Natl Acad Sci 91:957-961, 1994.
123. 2+ oscillations and gene transcription. Proc Natl Acad Sci 92:2725-2729, 1995.
124. Dinerstein H, Lago F, Goujon L, Ferrag F, Esposito N, Finidori J, Kelly PA, Postenl-Vinay M-C. The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription. Mol Endocrinol 9:1701-1707, 1995.
125. Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN. JAK2 associates with the βc chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335-4341, 1994.
126. Sotiropoulos A, Perrot-Applanat M, Dinerstein H, Pallier A, Postel-Vinay M, Finidori J, Kelly PA. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase and transcription. Endocrinology 135:1292-1297, 1994.
127. Zhao Y, Wagner F, Frank SJ, Kraft AS. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor βc chain. J Biol Chem 270:13814-13818, 1995.
128. 127a. Sigal NH, Dumont FJ. Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10:519-560, 1992.
129. 127b. Galat A. Peptidylproline cis-trans-isomerases: Immunophilins. Eur J Biochem 216:689-707, 1993.
130. 127c. O'Neal KD, Chari MV, McDonald CH, Cook RG, Yu-Lee L-Y, Morrisett JD, Shearer WT. Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy. Biochemical J 315:833-844, 1996.
131. Edery M, Levi-Meyrueis C, Paly J, Kelly PA, Djian J. A limited cytoplasmic region of the prolactin receptor critical for signal transduction. Mol Cell Endocrinol 102:39-44, 1994.
132. Miyazaki T, Liu Z-J, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, Taniguchi T. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81:223-231, 1995.
133. Greenlund AC, Farrar MA, Viviano BL, Schreiber RD. Ligand-induced IFN-gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J 13:1591-1600, 1994.
134. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701-1706, 1994.
135. Gaffen SL, Lai SY, Xu W, Gouilleux F, Groner B, Goldsmith MA, Greene WC. Signaling through the interleukin-2 receptor beta chain activates a Stat5-like DNA-binding activity. Proc Natl Acad Sci 92: 7192-7196, 1995.
136. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotrophy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339, 1995.
137. Stahl N, Farruggella TJ, Boulton TG, Zhong, Z, Darnell JE, Yancopoulos GD. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349-1353, 1995.
138. Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, Schreiber RD. Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process. Immunity 2:677-687, 1995.
139. Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL. Components of a Stat recognition code: Evidence for two layers of molecular selectivity. Immunity 2:689-697, 1995.
140. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weistein Y, Ihle JN. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol 16:1622-1631, 1996.
141. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. The role of the growth hormone (GH) receptor and Jak1 and Jak2 kinases in the activation of Stats1, 3, and 5 by GH. Mol Endocrinol 10:519-533, 1996.
142. Lobie PE, Allevato G, Nielsen JH, Norstedt G, Billestrup N. Requirement of tyrosine residues 333 and 338 of the growth hormone (GH) receptor for selected GH-stimulated function. J Biol Chem 270:21745-21750, 1995.
143. Wang Y-D, Wong K, Wood WI. Intracellular tyrosine residues of the human growth hormone receptor are not required for the signaling of proliferation of JAK-Stat activation. J Biol Chem 270:7021-7024, 1995.
144. Colosi P, Wong K, Leong SR, Woor WI. Mutational analysis of the intracellular domain of the human growth hormone receptor. J Biol Chem 268:12617-12623, 1993.
145. Fukunaga R, Ishizaka-Ikeda E, Nagata S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 74:1079-1087, 1993.
146. D'Andrea A, Yoshimura A, Youssoufian H, Zon LI, Koo J, Lodish HF. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth regulatory domains. Mol Cell Biol 11:1980-1987, 1991.
147. Sato N, Sakamaki K, Terada N, Arai K, Miyajima A. Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J 12:4181-4189, 1993.
148. c chain sufficient for Jak kinase activation and induction of proliferation in T cells. Mol Cell Biol 16:309-317, 1996.
149. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN. Involvement of Jak3 Janus kinase in signaling by interleukins 2 and 4 in lynmphoid and myeloid cells. Nature 370:153-157, 1994.
150. Tum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J 14:1412-1420, 1995.
151. Zhuang HM, Patel SV, He TC, Sonsteby SK, Niu ZT, Wojchowski DM. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J Biol Chem 269:21411-21414, 1994.
152. Duhe RJ, Farrar WL. Characterization of active and inactive forms of the JAK2 protein-tyrosine kinase produced via the baculovirus expression vector system. J Biol Chem 270:23085-23090, 1995.
153. Velazquez L, Mogensen KE, Barbieri G, Fellous M, Uze G, Pellegrini S. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-α/β and for signal transduction. J Biol Chem 270:3327-3334, 1995.
154. Frank SJ, Yi W, Zhao Y, Goldsmith JF, Gilliland G, Jiang J, Sakai K, Kraft AS. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem 270:14776-14785, 1995.
155. Gao J, Hughes JP, Auperin B, Buteau H, Edery M, Zhuang H, Woychowski DM, Horseman ND. Interactions among JANUS kinases and the prolactin (PRL) receptorin the regulation of a PRL response element. Mol Endocrinol 10:847-856, 1996.
156. Pawson T, Gish GD. SH2 and SH3 domains: From structure to function. Cell 71:359-362, 1992.
157. Yi T, Mui AL-F, Krystal G, Ihle JN. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor β chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 13:7577-7586, 1993.
158. Hunter T. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80:225-236, 1995.
159. Pei D, Wang J, Walsh CT. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proc Natl Acad Sci 93:1141-1145, 1996.
160. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish FH. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals, Cell 80:729-738, 1995.
161. David M, Chen HE, Goelz S, Larner AC, Neel BG. Differential regulation of the alpha/beta interferon-stimulated JAK/STAT pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15:7050-7058, 1995.
162. Petricoin E, David M, Igarashi K, Benjamin C, Ling L, Goelz S, Finbloom D, Larner AC. Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase. Mol Cell Biol 16:1419-1424, 1996.
163. Ali S, Chen Z, Lebrun J-J, Vogel W, Kharitonenkov A, Kelly PA, Ullrich A. PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J 15:135-142, 1996.
164. Pellegrini S, Schindler C. Early events in signalling by interferons. Trends Biochem Sci 18:338-342, 1993.
165. Rothman P, Kreider B, Azam M, Levy D, Wegenka U, Eilers A, Decker T, Forn F, Kashieva H, Ihle J, Schindler C. Cytokines and growth factors signal through tyrosine phosphorylation of a family of related transcription factors. Immunity 1:457-468, 1994.
166. Ihle JN. STATs: Signal transducers and activators of transcription. Cell 43:331-334, 1996.
167. Yan R, Small S, Desplan C, Dearolf CR, Darnell JE Jr. Identification of a Stat gene that functions in Drosphila development. Cell 84:421-430, 1996.
168. Hou XS, Melnick MB, Berrimon N. Marella acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 84:411-419, 1996.
169. Yan R, Qureshi S, Zhong Z, Wen Z, Darnell JE. The genomic structure of the STAT genes: Multiple exons in coincident sites in Stat1 and Stat2. Nucleic Acids Res 23:459-463, 1995.
170. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr. Activation of transcription by IFN-gamma: Tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808-1812, 1992.
171. Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell JE Jr. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-pohsphotyrosyl peptide interactions. Cell 76:821-828, 1994.
172. Azam M, Erdjument-Bromage H, Kreider BL, Xia M, Quelle F, Basu R, Saris C, Tempst P, Ihle JN, Schindler C. Interleukin-3 signals through multiple isoforms of Stat5. EMBO J 14:1402-1411, 1995.
173. Kazansky AV, Raught B, Lindsey SM, Wang Y-F, Rosen JM. Regulation of MGF/STAT5a during mammary gland development. Mol Endocrinol 9:1598-1609, 1995.
174. Schaefer TS, Sanders LK, Nathans D. Cooperative transcriptional activity of Jun and Stat3β, a short form of Stat3. Proc Natl Acad Sci 92:9097-9101, 1995.
175. Moriggl R, Fouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 16:5691-5700, 1996.
176. Wen ZL, Zhong Z, Darnell JE. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250, 1995.
177. Leung S, Li X, Stark GR. Stats find that hanging together can be stimulating. Science 273:750-751, 1996.
178. Horvath CM, Wen Z, Darnell JE. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9:984-994, 1995.
179. Heim MH, Kerr IM, Stark GR, Darnell JE. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267:1347-1349, 1995.
180. Schindler C, Shuai K, Prezioso VR, Darnell JE Jr. Interferon-dependent lyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809-815, 1992.
181. Shuai K, Stark GR, Kerr IM, Darnell JE Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261:1744-1746, 1993.
182. Zhang X, Blenis, J, Li HC, Schindler C, Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990-1994, 1995.
183. Eilers A, Georgellis D, Klose B, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Decker T. Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages. Mol Cell Biol 15:3579-3586, 1995.
184. David M, Petricoin E, Benjamin C, Pine R, Weber MJ, Larner AC. Requirement for MAP kinase (ERK2) activity in interferon α and interferon β stimulated gene expression through STAT proteins. Science 269:1721-1723, 1995.
185. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse J-F, Capiod J-C, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemic patients. Blood 87:1692-1697, 1996.
186. Carlesso N, Frank DA, Griffin JD. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811-820, 1996.
187. Shuai K, Liao J, Song MM. Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol Cell Biol 16:4932-4941, 1996.
188. David M, Grimley PM, Finbloom DS, Larner AC. A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol Cell Biol 13:7515-7521, 1993.
189. Igarashi K, David M, Finbloom DS, Larner AC. In vitro activation of the transcription factor gamma interferon activation factor by gamma interferon: evidence for a tyrosine phosphatase/ kinase signaling cascade. Mol Cell Biol 13:1634-1640, 1993.
190. Haque SJ, Flati V, Deb A, Williams BRG. Role of protein-tyrosine phosphatases in Stat1α-mediated cell signaling. J Biol Chem 270:25709-25714, 1995.
191. Kessler DS, Veals SA, Fu X-Y, Levy DE. Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 4:1753-1765, 1990.
192. Bluyssen HAR, Muzaffar R, Vlieststra RJ, Van der Made ACJ, Leung S, Stark GR, Kerr IM, Trapman J, Levy DE. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci 92:5645-5649, 1995.
193. Decker T, Lew DJ, Mirkovitch J, Darnell JE Jr. Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor. EMBO J 10:927-932, 1991.
194. Seidel HM, Milocco LH, Lamb P, Darnell JE Jr., Stein RB, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci 92:3041-3045, 1995.
195. Li X, Leung S, Qureshi S, Darnell JE Jr., Stark GR. Formation of Stat1-Stat2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J Biol Chem 271:5790-5794, 1996.
196. Sadowski HB, Shuai K, Darnell JE Jr., Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739-1744, 1993.
197. Raz R, Durbin JE, Levy DE. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J Biol Chem 269:24391-24395, 1994.
198. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 270:30264-30267, 1995.
199. Cao X, Tay A, Guy G, Tan YH. Activation and associatlion of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603, 1996.
200. Stocklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728, 1996.
201. Xu X, Sun Y-L, Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the Stat amino-terminal domain. Science 273:794-797, 1996.
202. Wakao H, Gouilleux F, Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 13:2182-2191, 1994.
203. Weite T, Garimorth K, Philipp S, Doppler W. Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells. Mol Endocrinol 8:1091-1102, 1994.
204. Gouilleux F, Wakao H, Mundt M, Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 13:4361-4369, 1994.
205. Gilmour KC, Reich NC. Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. Proc Natl Acad Sci 91:6850-6854, 1994.
206. Gilmour KC, Pine R, Riech NC. Interleukin 2 activates Stat5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci 92:10772-10776, 1995.
207. Gouilleux F, Moritz D, Humar M, Moriggl R, Berchtold S, Groner B. Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-Stat5-like transcription factor. Endocrinology 136:5700-5708, 1995.
208. Wang Y-F, Yu-Lee L-Y. Multiple Stat complexes interact at the JRF-1 GAS in prolactin-stimulated Nb2 T cells. Mol Cell Endocrinol 121:19-28, 1996.
209. Burdon TG, Demmer J, Clark JA, Watson CJ. The mammary factor MPBF is a prolactin-induced transcriptional regulator which binds to STAT factor recognition sites. Fed Eur Biochem Soc 350:177-182, 1994.
210. Demmer J, Burdon TG, Dijane J, Watson CJ, Clark AJ. The proximal milk protein binding factor binding site is required for the prolactin responsiveness of the sheep β-lactoglobulin promoter in Chinese hamster ovary cells. Mol Cell Endocrinol 107:113-121, 1995.
211. Li S, Rosen JM. CTF/NF1 and mammary gland factor (Stat5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol Cell Biol 15:2063-2070, 1995.
212. 2-macroglobulin gene in rat ovarian granulosa cells: Stat5 activation and binding to the interleukin-6 response element. Mol Endocrinol 10:171-184, 1996.
213. David M, Petricoin EF III, Igarashi K-I, Feldman GM, Finbloom DS, Larner AC. Prolactin activates the interferon-regulated p91 transcription factor and the Jak2 kinase by tyrosine phosphorylation. Proc Natl Acad Sci 91:7174-7178, 1994.
214. Stevens AM, Wang Y-F, Sieger KA, Lu H-F, Yu-Lee L-Y. Biphasic transcriptional regulation of the interferon regulatory factor-1 gene by prolactin: Involvement of gamma-interferon activated sequence and Stat-related proteins. Mol Endocrinol 9:513-525, 1995.
215. DaSilva L, Rui H, Erwin RA, Howard OMZ, Kriken RA, Malabarba MG, Hackett RH, Larner AC, Farrar WL. Prolactin recruits Stat1, Stat3, and Stat5 independent of conserved receptor tyrosines Tyr402, Tyr479, Tyr515 and Tyr580. Mol Cell Endocrinol 117:131-140, 1996.
216. Meier VS, Groner B. The nuclear factor YY1 participates in repression of the β-casein gene promoter in mammary epithelial cells and is counteracted by mammary gland factor during lactogenic hormone induction. Mol Cell Biol 14:128-137, 1994.
217. Raught B, Khursheed B, Kanzansky A, Rosen J. YY1 represses β-casein gene expression by preventing the formation of a lactation-associated complex. Mol Cell Biol 14:1752-1763, 1994.
218. Raught B, Liao WS-L, Rosen JM. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence β-casein gene expression. Mol Endocrinol 9:1223-1232, 1995.
219. Ruff-Jamison S, Chen K, Cohen S. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat5 in liver. Proc Natl Acad Sci 92:4215-4218, 1995.
220. Lai C-F, Ripperger J, Morella KK, Wang Y, Gearing DP, Horseman ND, Campos SP, Fey GH, Baumann H. STAT3 and STAT5B are targets of two different signal pathways activated by hematopoietin receptors and control transcription via separate cytokine response elements. J Biol Chem 270:23254-23257, 1995.
221. Liu X, Robinson GW, Hennighausen L. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol 10:1496-1506, 1996.
222. fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol Endocrinol 8:674-681, 1994.
223. Clevenger CV, Torigoe T, Reed JC. Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J Biol Chem 269:5559-5565, 1994.
224. Berlanga, JJ, Vara JAF, Martin-Perez J, Garcia-Ruiz JP. Prolactin receptor is associated with c-src kinase in rat liver. Mol Endocrinol 9:1461-1467, 1995.
225. Rao Y-P, Buckley DJ, Buckley AR. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin-2 in rat Nb2 node lymphoma cells. Cell Growth Diff 6:1235-1244, 1995.
226. Erwin RA, Kirken RA, Malabarba MG, Farrar WL, Rui H. Prolactin activates Ras via signaling proteins SHC, Growth Factor Receptor Bound 2, and Son of Sevenless. Endocrincology 136:3512-3518, 1996.
227. Fields S, Song O-Y. A novel genetic system to detect protein-protein interactions. Nature 340:245-246, 1989.
228. Tanaka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 51:1058-1063, 1980.
229. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739, 1989.
230. Nelson N, Marks MS, Driggers PH, Ozato K. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol 13:588-599, 1993.
231. Veals SA, Schinder C, Leonard D, Fu X-Y, Aebersold R, Darnell JE Jr., Levy DE. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol 12:3315-3324, 1992.
232. Eisenbeis CF, Singh H, Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 9:1377-1387, 1995.
233. Au W-C, Moore PA, Lowther W, Juang Y-T, Pitha PM. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci 92:11657-11661, 1995.
234. Bovolenta C, Driggers PH, Marks MS, Medin JA, Politis AD, Vogel SN, Levy DE, Sakaguchi K, Appella E, Cotigan JE, Ozato K. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci 91:5046-5050, 1994.
235. Schwarz LA, Stevens AM, Hrachovy JA, Yu-Lee L-Y. Interferon regulatory factor-1 is inducible by prolactin, interleukin-2 and concanavalin A in T cells. Mol Cell Endocrinol 86:103-110, 1992.
236. Clevenger CV, Sillman AL, Hanley-Hyde J, Prystowsky MB. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 130:3216-3222, 1992.
237. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54:903-913, 1988.
238. Ting JP-Y, Baldwin AS Jr. Regulation of MHC gene expression. Curr Opin Immunol 5:8-16, 1993.
239. Sims SH, Cha Y, Romaine MF, Gao P-Q, Gottlieb K, Deisseroth AB. A novel interferon-inducible domain: Structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 13:690-702, 1993.
240. Pine R. Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J Virol 66:4470-4478, 1992.
241. Fujita T, Reis LF, Watanabe N, Kimura Y, Taniguchi T, Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci 86:9936-9940, 1989.
242. Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: Role in growth inhibition. Cell Growth Diff 2:401-407, 1991.
243. Harroch S, Gothelf Y, Watanabe N, Revel M, Chebath J. Interleukin-6 activates and regulates transcription factors of the interferon regulatory factor family in Ml cells. J BiolChem 268:9092-9097, 1993.
244. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971, 1993.
245. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T. Antioncogenic and oncogenic potentials of interferon regulator factors-1 and -2. Science 259:971-974, 1993.
246. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TNV, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-1615, 1994.
247. Martin E. Nathan C, Xie Q-W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180:977-984, 1994.
248. Chang C-H, Hammer J, Loh JE, Fodor WL, Flavel RA. The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 35:378-384, 1992.
249. Johnson DR, Pober JS. HLA class I heavy-chain gene promote elements mediating synergy between tumor necrosis factor and interferons. Mol Cell Biol 14:1322-1332, 1994.
250. Yamada G, Ogawa M, Akagi K, Miyamoto H, Nakano N, Itoh S, Miyazaki J-I, Nishikawa S-I, Yamamura K-I, Taniguchi T. Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci 88:532-536, 1991.
251. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Narendran A, Suzuki H, Ohashi PS, Paige CJ, Taniguichi T, Mak TW. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83-97, 1993.
252. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Aizawa S, Mak TW, Taniguchi T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77:829-839, 1994.
253. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matusyama T, Mak TW, Taki S, Taniguchi T. An IRF-1-dependent pathway of DBA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376:596-599, 1995.
254. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T. Cooperation of the tumour suppressor IRF-1 and p53 in response to DNA damage. Nature 382:816-818, 1996.
255. Reis LFL, Ruffner H, Stark G, Aguet M, Weissmann C. Mice devoid of interferon regulatory factor 1 (IRF 1) show normal expression of type I interferon genes. EMBO J 13:4798-4806, 1994.
256. Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak TW, Taniguchi T. Involvement of IRF-1 transcription factor in antiviral responses to interferons. Science 264:1921-1924, 1994.
257. Nelson N, Kanno Y, Hong C, Contursi C, Fujita T, Fowlkes BJ, O'Connell E, Hu-Li J, Paul WE, Jankovic, D, Sher AF, Coligan JE, Thornton A, Appella E, Yang Y, Ozato K. Expression of IFN regulatory factor family proteins in lymphocytes: Induction of Stat1 and IFN concensus sequence binding protein expression by T cell activation. J Immunol 156:3711-3720, 1996.
258. Stevens AM, Yu-Lee L-Y. The transcription factor interferon regulatory factor-1 is expressed during both early G1 and the G1/S transition in the prolactin-induced lymphocyte cell cycle. Mol Endocrinol 6:2236-2243, 1992.
259. Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63:303-312, 1990.
260. Matikainen S, Ronni T, Hurme M, Pine R, Julkunen I. Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 88:114-123, 1996.
261. Stevens AM, Yu-Lee L-Y. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol Endocrinol 8:345-355, 1994.
262. Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35:79-87, 1983.
263. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511, 1993.
264. Hu Q, Lees JA, Buchkovich KJ, Harlow E. The retinoblastoma protein physically associates with the human cdc2 kinase. Mol Cell Biol 12:971-980, 1992.
265. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357, 1995.
266. Gill G, Pascal E, Tseng ZH, Tjian R. A glutamine-rich hydrophobic patchin transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci 91:192-196, 1994.
267. 263a. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM. Cooperation of Stat2 and p300/ CBP in signaling induced by interferon-α. Nature 383:344-347, 1996.
268. 263b. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JE, Jr. Two contact regions between Stat1 and CBP/ p300 in interferon-γ signaling. Proc Natl Acad Sci 93:15092-15096, 1996.
269. 263c. Horvai A, Xu L, Korzus E, Brard D, Kalafus D, Mullen T-M, Rose DW, Rosenfeld MG, Glass CK. Nuclear integration of Jak/ Stat and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci 94:1074-1079, 1997.
270. 1/S phase by a complex that contains retinoblastoma-like protein and a cdc2 kinase. Proc Natl Acad Sci 89:3256-3260, 1992.
271. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor-1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 13:4531-4538, 1993.
272. 4 in Saccharomyces cerevisiae. Gene Expression 2:329-337, 1992.
273. Pleiman CM, Gimpel SD, Park LS, Harada H, Taniguchi T, Zeigler SF. Organization of the murine and human interleukin-7 receptor genes: Two mRNAs generated by differential splicing and presence of a type-I-interferon-inducible promoter. Mol Cell Biol 11:3052-3059, 1991.
274. Girdlestone J, Ismat M, Gewert D, Milstein C. Transcriptional regulation of HLA-A and -B: Differential binding of members of Rel and IRF families of transcription factors. Proc Natl Acad Sci 90:11568-11572, 1993.
275. Li-Weber M, Davydov IV, Krafft H, Krammer PH. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J Immunol 153:4122-4132, 1994.
276. Min W, Pober JS, Johnson DR. Kinetically coordinated induction of TAP1 and HLA Class I by IFN gamma. J Immunol 156:3174-3183, 1996.
277. Coccia EM, Marziali G, Stellacci E, Perrotti E, Ilari R, Orsatti R, Battistini A. Cells resistant to interferon-β respond to interferon-gamma via the Stat1-IRF-1 pathway. Virology 211:133-122, 1995.
278. Tanaka H, Samuel CE. Mechanism of interferon action: Structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc Natl Acad Sci 91:7995-7999, 1996.
279. Kirchhoff S, Koromilas AE, Schaper F, Grashoff M, Sonenberg N, Hauser H. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11:439-445, 1995.
280. Beretta L, Gabbay M, Berger R, Hanash SM, Sonenberg N. Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12:1593-1596, 1996.
281. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human interleukin-6 gene by interferon gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NFκB, and Sp1 transcription factors. J Biol Chem 270:27920-27931, 1995.
282. Manzella L, Giuffrida MA, Pilastro MR, Girlando G, Picardi G, Malaguarnera L, Messina A. Possible role of the transcription factor interferon regulatory factor-1 (IRF-1) in the regulation of ornithine decarboxylase (ODC) gene expression during IFN gamma macrophage activation. FEBS Lett 348:177-180, 1994.
283. Horiuchi M, Koike G, Yamada T, Mukoyama M, Nakajima M, Dzau VJ. The growth-dependent expression of angiotensin II type 2 receptor is regulation by transcription factors interferon regulatory factor-1 and -2. J Biol Chem 270:20225-20230, 1995.
284. Decker T, Lew DJ, Darnell JE Jr. Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene. Mol Cell Biol 11:5147-5153, 1991.
285. Briken V, Ruffner H, Schultz U, Schwartz A, Reis LFL, Strehlow I, Decker T, Staeheli P. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol Cell Biol 15:975-982, 1995.
286. Harroch S, Gothelf Y, Revel M, Chebath J. 5′ upstream sequences of MyD88, an IL-6 primary response gene in M1 cells: Detection of functional IRF-1 and Stat factors binding sites. Nucleic Acids Res 23:3539-3546, 1994.
287. Harada H, Takahashi E-I, Itoh S, Harada K, Hori T-A, Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: Implications for a gene network in the interferon system. Mol Cell Biol 14:1500-1509, 1994.
288. Taniguchi T, Harada H, Lamphier M. Regulation of the interferon system and cell growth by the IRF transcription factors. J Cancer Res Clin Oncol 121:516-520, 1995.
289. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T. Endothelial interferon regulatory factor-1 cooperates with NF-(kappa)B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15:2558-2569, 1995.
290. Massa PT, Wu HL. Interferon regulatory factor element and interferon regulatory factor-1 in the induction of major histocompatibility complex Class I genes in neural cells. J Interferon Cyto Res 15:799-810, 1995.
291. Du W, Thanos D, Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74:887-898, 1993.
292. Stein B, Baldwin AS Jr., Ballard DW, Greene WC, Angel P, Herrlich P. Cross-coupling of the NFκB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12:3879-3891, 1993.
293. Stein B, Cogswell PC, Baldwin AS Jr. Functional and physical associations between NFκB and C/EBP family members: A Rel domain-bZIP interaction. Mol Cell Biol 13:3946-3974, 1994.
294. Taneka N, Ishihara M, Taniguchi T. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Cancer Lett 83:191-196, 1994.
295. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med 180:1955-1960, 1994.
296. Sudo T, Nishikawa S, Ohno N, Akiyama N, Tamakoshi M, Yoshida H, Nishikawa S-I. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci 90:9125-9129, 1993.
297. + T cells in TAP1-mutant mice by human β2-microglobulin transgene. J Exp Med 181:787-792, 1995.
298. Leff MA, Buckley DJ, Krumenacker J, Reed JC, Miyashita Y, Buckley AR. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology 137:5456-5462, 1996.